Skip to main content
OLYMPUS CORPORATION logo

OLYMPUS CORPORATION — Investor Relations & Filings

Ticker · 7733 ISIN · JP3201200007 LEI · 5299000Y52IFDI1I2A21 T Manufacturing
Filings indexed 102 across all filing types
Latest filing 2026-05-26 M&A Activity
Country JP Japan
Listing T 7733

About OLYMPUS CORPORATION

https://www.olympus-global.com/

Olympus Corporation is a global medical technology (medtech) company focused on making people's lives healthier, safer, and more fulfilling. The company develops, manufactures, and commercializes innovative solutions for the medical and healthcare sectors, specializing in early detection, diagnosis, and minimally invasive treatment. Its core product portfolio includes medical endoscopes, endotherapy devices, and therapeutic energy devices. These technologies are applied across various medical specialties such as gastroenterology, urology, gynecology, and general surgery. Leveraging its expertise in optical and digital precision technology, Olympus provides comprehensive solutions that also encompass advanced video imaging systems and system integration services for healthcare facilities.

Recent filings

Filing Released Lang Actions
BioProtect Ltd.の株式の取得(子会社化)に関するお知らせ
M&A Activity Classification · 90% confidence The document is a Japanese IR announcement from Olympus detailing its decision to acquire 100% of BioProtect Ltd.’s shares and make it a wholly owned subsidiary. It includes the purpose of the acquisition, target company details, number of shares acquired, acquisition price, dates, and pro forma financial outlook. This is an M&A transaction announcement, which best fits the “M&A Activity” category (Code: TAR) rather than a financing update or regulatory fall-back.
2026-05-26 Japanese
発行登録追補書類(株券、社債券等)
Share Issue/Capital Change Classification · 95% confidence The document is an issuance registration supplementary filing (発行登録追補書類) submitted to the Kanto Local Finance Bureau, detailing the terms, conditions, amounts, allotment methods, and related information for an issuance of shares (including disposal of treasury shares under RSU/PSU programs). It is not an earnings release, annual report, proxy statement, or mere announcement—it is the formal prospectus-like registration for a share issuance. According to the category definitions, this falls under Share Issue/Capital Change (SHA).
2026-05-14 Japanese
自己株式立会外買付取引(ToSTNeT-3)による自己株式の買付けに関するお知らせ
Transaction in Own Shares Classification · 95% confidence The document is a notice from Olympus Corporation detailing the Board of Directors’ resolution and specific method for acquiring treasury shares (share buyback) under the Companies Act and the company’s Articles. It includes the repurchase mechanism (ToSTNeT-3), maximum number of shares, total purchase amount, and timing. This clearly falls under “Transaction in Own Shares” (share repurchase) rather than a new share issuance or other capital change.
2026-05-12 Japanese
訂正発行登録書
Regulatory Filings Classification · 62% confidence The document is a Japanese “訂正発行登録書” (Correction Issuance Registration Statement) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act for corporate bond issuance. It is a statutory disclosure regarding a securities registration change, not an earnings release, management change, or AGM material. This type of bond registration filing does not fit any more specific category, so it falls under the general “Regulatory Filings” category (RNS).
2026-04-28 Japanese
訂正発行登録書
Share Issue/Capital Change Classification · 90% confidence The document is a Japanese “訂正発行登録書” (Amended Issuance Registration Statement) filed with the Kanto Local Finance Bureau, detailing the registration for a stock issuance (issue amount, effective periods, registration number, etc.). This is not an earnings, annual, or management report, but a formal notice of share issuance registration. It fits the “Share Issue/Capital Change” category.
2026-04-28 Japanese
臨時報告書
Share Issue/Capital Change Classification · 91% confidence The document is a Japanese '臨時報告書' filed with the Kanto Finance Bureau under the Financial Instruments and Exchange Act, detailing the issuance/disposal of 4,219,887 shares (PSU/RSU) to executives and employees, including the issue price and vesting conditions. This is a specific capital change via share issuance (using treasury shares). It is not an annual or interim financial report, earnings release, management change, or simply a publication notice. It clearly outlines a new share issuance related to employee remuneration, fitting the 'Share Issue/Capital Change' category.
2026-04-28 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.